SILG.L vs. GNOG.L
SILG.L (Global X Silver Miners UCITS ETF USD Accumulating) and GNOG.L (Global X Genomics & Biotechnology UCITS ETF) are both exchange-traded funds - SILG.L is a Silver fund tracking the Solactive Global Silver Miners Total Return v2 Index, while GNOG.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD. Both are passively managed. Over the past 3 years, SILG.L returned 45.51%/yr vs -1.86%/yr for GNOG.L. At a 0.19 correlation, their price movements are largely independent. SILG.L charges 0.65%/yr vs 0.50%/yr for GNOG.L.
Performance
SILG.L vs. GNOG.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SILG.L achieves a 5.62% return, which is significantly lower than GNOG.L's 12.27% return.
SILG.L
- 1D
- 0.35%
- 1M
- 2.67%
- YTD
- 5.62%
- 6M
- 16.67%
- 1Y
- 98.68%
- 3Y*
- 45.51%
- 5Y*
- —
- 10Y*
- —
GNOG.L
- 1D
- 5.70%
- 1M
- 13.66%
- YTD
- 12.27%
- 6M
- 9.47%
- 1Y
- 59.40%
- 3Y*
- -1.86%
- 5Y*
- —
- 10Y*
- —
SILG.L vs. GNOG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
SILG.L Global X Silver Miners UCITS ETF USD Accumulating | 5.62% | 153.98% | 13.53% | -6.34% | -8.01% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | 12.27% | 12.03% | -16.98% | -11.35% | 4.83% |
Correlation
The correlation between SILG.L and GNOG.L is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since May 9, 2022 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SILG.L vs. GNOG.L — Risk / Return Rank
SILG.L
GNOG.L
SILG.L vs. GNOG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Silver Miners UCITS ETF USD Accumulating (SILG.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SILG.L | GNOG.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.18 | ||
| Sortino ratioReturn per unit of downside risk | -0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.35 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.16 | 3.44 | -0.29 |
| Martin ratioReturn relative to average drawdown | 7.69 | 8.72 | -1.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SILG.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.98 | 2.16 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.68 | -0.36 | +1.03 |
Drawdowns
SILG.L vs. GNOG.L - Drawdown Comparison
The maximum SILG.L drawdown since its inception was -32.00%, smaller than the maximum GNOG.L drawdown of -67.50%. Use the drawdown chart below to compare losses from any high point for SILG.L and GNOG.L.
Loading charts...
Drawdown Indicators
| SILG.L | GNOG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.00% | -67.50% | +35.50% |
Max Drawdown (1Y)Largest decline over 1 year | -30.90% | -17.16% | -13.74% |
Max Drawdown (3Y)Largest decline over 3 years | -30.90% | -47.97% | +17.07% |
Current DrawdownCurrent decline from peak | -24.56% | -41.78% | +17.22% |
Average DrawdownAverage peak-to-trough decline | -12.52% | -44.20% | +31.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.74% | 6.79% | +5.95% |
Volatility
SILG.L vs. GNOG.L - Volatility Comparison
Global X Silver Miners UCITS ETF USD Accumulating (SILG.L) has a higher volatility of 18.48% compared to Global X Genomics & Biotechnology UCITS ETF (GNOG.L) at 7.97%. This indicates that SILG.L's price experiences larger fluctuations and is considered to be riskier than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SILG.L | GNOG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.48% | 7.97% | +10.51% |
Volatility (6M)Calculated over the trailing 6-month period | 39.95% | 19.73% | +20.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.23% | 27.38% | +21.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.40% | 31.21% | +8.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.40% | 31.21% | +8.19% |
SILG.L vs. GNOG.L - Expense Ratio Comparison
SILG.L has a 0.65% expense ratio, which is higher than GNOG.L's 0.50% expense ratio.
Dividends
SILG.L vs. GNOG.L - Dividend Comparison
Neither SILG.L nor GNOG.L has paid dividends to shareholders.
Frequently Asked Questions
SILG.L and GNOG.L have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GNOG.L is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GNOG.L is cheaper with a 0.50% expense ratio, compared with 0.65% for SILG.L.
SILG.L is categorized as Silver, while GNOG.L is Health & Biotech Equities. SILG.L tracks Solactive Global Silver Miners Total Return v2 Index, while GNOG.L tracks MSCI World/Health Care NR USD. Their fees differ too: 0.65% for SILG.L and 0.50% for GNOG.L.
Find the right allocation for SILG.L and GNOG.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer